Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 8, 2018

View Archived Issues

Blood protein networks linked to complex diseases

Multigene assay constructed to predict late recurrence in ER-positive breast cancer

Suppressive role of exosomal TRIM3 in gastric cancer growth: potential biomarker and therapy target

First patients dosed in phase I/II study of FX-322

Salvensis patents compounds for schistosomiasis

Resverlogix announces seventh positive recommendation for phase III study of apabetalone

Korean researchers divulge new antiviral compounds

Data analysis completed for second cohort in part I of phase I/IIa study of CRV-431

U.S. researchers identify ITGA5 antagonists

NHRI synthesizes new CXCR4 ligands

Sichuan Kelun-Biotech Biopharmaceutical patents FXR agonists

Neuroendocrine stress pathways mediate the adverse health effects of air pollution

Plant-derived compound silvestrol inhibits HEV replication with additive effect to ribavirin

FDA expands approval of Orkambi to children 2 to 5 years of age

Researchers present new anti-CRH MAb for AD downstream pathologies

ADC Therapeutics begins dosing in registrational phase II trial evaluating ADCT-402

DMC recommends early continuation of phase III GENESIS study of BL-8040

Recruitment underway in TaiRx's phase II study of CMV-118 in combination with sorafenib

New sulfonamide is potent anti-breast cancer agent

Aged rhesus monkey shows same pattern of tau pathology as humans

Teneobio and Poseida to use UniDabs to develop CAR-T therapies

New biological target for Alzheimer's identified in BioArctic/Eisai collaboration

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 5, 2026.
New York University identifies new analogues of mannose-6-phosphate
BioWorld Science
New York University has discovered new analogues of mannose-6-phosphate reported to be potentially useful for the treatment of memory impairment,...
Bial-Portela discovers new OX1 receptor antagonists
BioWorld Science
Bial-Portela & Ca SA has patented new orexin OX1 receptor antagonists potentially useful for the treatment of anxiety disorders, depression, eating disorders,...
FB-7033 demonstrates efficacy in MASH management
BioWorld Science
17-β-Hydroxysteroid dehydrogenase 13 (HSD17B13) and lipid transferase CIDEB are known to contribute to metabolic dysfunction-associated steatohepatitis (MASH)...
Preclinical results support Actinium’s radioconjugate ATNM‑400 for NSCLC
BioWorld Science
At the recent meeting of the Society of Nuclear Medicine and Molecular Imaging, researchers from Actinium Pharmaceuticals Inc. presented preclinical efficacy data...